Transaction in Own Shares | Financial Post


The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020)  through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.



Source link

  • Related Posts

    Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use

    Based in East Brunswick, New Jersey, Cronus Pharma is a privately held veterinary generic pharmaceutical company dedicated to advancing animal health. With integrated research, development, manufacturing, and marketing, we deliver…

    4 reasons Nvidia stock is lagging

    Nvidia’s (NVDA) stock isn’t having its typical year. No epic gains on earning reports. Nvidia stock has fallen in response to earnings in six of the past eight quarters, including…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Minister Joly to attend NATO Foreign Ministers’ Meeting in Belgium

    Minister Joly to attend NATO Foreign Ministers’ Meeting in Belgium

    2026 Fantasy football draft strategy: Best approach for every pick

    2026 Fantasy football draft strategy: Best approach for every pick

    99 Zero Waste Hacks We Learned From Our Grandparents

    99 Zero Waste Hacks We Learned From Our Grandparents

    Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use

    Free Accounts Can Now Access ChatGPT’s Upgraded Task Scheduling Tool

    Free Accounts Can Now Access ChatGPT’s Upgraded Task Scheduling Tool

    Stage Tour Is Looking More And More Like The Guitar Hero Revival We Sorely Need

    Stage Tour Is Looking More And More Like The Guitar Hero Revival We Sorely Need